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82 The Journal of Thoracic and Cardiobjective: The study objective was to describe the independent effect of preoper-
tive atrial fibrillation on the outcome of coronary artery bypass grafting, including
he causes of death (cardiac vs noncardiac).
ethods: We analyzed the outcome of patients with preoperative atrial fibrillation
ho underwent on-pump coronary artery bypass grafting between 1993 and 2002
nd compared them with matched controls in sinus rhythm; matching variables were
ge, gender, ejection fraction, and numbers of diseased coronary arteries and distal
nastomoses. Direct patient follow-up focused on late complications and reinter-
entions, and we investigated causes for all deaths.
esults: Operative mortality (1.6% vs 1.9%, P  .79) was similar in patients with
reoperative atrial fibrillation (n  257) compared with patients in sinus rhythm (n
269). The patients with atrial fibrillation had longer hospital stays (9  6 days vs
 6 days, P  .0008) and a trend to more frequent early readmissions (13% vs
%, P  .08). During follow-up (median 6.7 years, maximum 12 years), late
ospital admission was more frequent in patients with atrial fibrillation (59% vs
1%, P .0001). Risk of late mortality (all causes) in patients with atrial fibrillation
as increased by 40% compared with patients in sinus rhythm (P  0.02), and the
ate cardiac death rate in the atrial fibrillation group was 2.8 times that of the sinus
hythm group (P  .0004). Major adverse cardiac events occurred in 70% of
atients with preoperative atrial fibrillation compared with 52% of patients in
reoperative sinus rhythm (P  .0001). Subsequent rhythm-related intervention,
ncluding pacemaker implantations, was more common in the atrial fibrillation
roup (relative risk  2.1, P  .0027).
onclusions: Uncorrected preoperative atrial fibrillation in patients undergoing
oronary artery bypass grafting is associated with increased late cardiac morbidity
nd mortality and poor long-term survival. These data support consideration of atrial
brillation surgery at the time of coronary artery bypass grafting.
trial fibrillation (AF) is a common tachyarrhythmia, affecting approxi-
mately 2.2 million people in the United States, and the median age of
patients with AF is 70 years.1 As a result of the increasing age of patients
equiring myocardial revascularization and the predisposing influence of ischemic
eart disease, AF is not infrequent in patients undergoing coronary artery bypass
rafting (CABG). Several population-based studies and nonsurgical reports2-4 have
dentified AF as a marker of increased cardiovascular morbidity and mortality
ecause of its association with other cardiovascular diseases. There are few studies
xamining the impact of concurrent AF on the long-term outcome in patients after
urgical correction of the associated cardiovascular disease.
Quader and associates5 reported a reduction in long-term survival in patients
ndergoing CABG with preoperative AF and recommended concomitant surgical
vascular Surgery ● January 2007
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CDblation. Apart from this study, which focused only on
verall survival, there are no studies that comprehensively
valuate the long-term adverse effects of uncorrected pre-
perative AF after CABG in patients receiving optimal
edical treatment. Moreover, the impact of the clinical type
nd duration of AF on outcome in this patient population is
ot known. Because of current enthusiasm for surgical
blation of AF, it is important to investigate the influence of
F on outcome to identify which patients might benefit
rom concomitant ablation procedures.
The objectives of this study were to determine the prev-
lence of AF in patients undergoing CABG and to compare
he early and late clinical outcome between patients with
reoperative AF and patients in normal sinus rhythm (SR),
ith specific reference to adverse cardiac and cerebrovas-
ular events and long-term survival; further, the study ad-
ressed the influence of type and duration of AF on clinical
utcome.
atients and Methods
tudy Population and Matching
he cardiovascular surgery database of our institution contains
nformation on 7498 patients who underwent isolated CABG be-
ween January 1993 and December 2002, of whom 650 (8.7%) had
reoperative AF. The institutional review board approved the use
f patients’ data for this study. Patients were excluded if they had
history of cardiac arrhythmia other than AF, permanent sequelae
f stroke, prior implantation of a permanent pacemaker or cardio-
erter defibrillator, prior AF ablation, surgery within 7 days of
cute myocardial infarction, and off-pump CABG. Patients with
ancer who had a limited life expectancy were also excluded. Of
151 patients who met the study criteria and for whom complete
atching variables were available, 284 had preoperative AF con-
rmed by electrocardiograms, and 3867 were in SR.
Previous publications suggested a 10% reduction in late sur-
ival of patients with AF undergoing CABG compared with con-
rols; with these data, we estimated that 200 patients would be
eeded in each group to demonstrate this difference (90% power).
e then used the Greedy method6 to identify the best matched
ontrol (preoperative SR) for each case based on age, gender,
jection fraction, extent of coronary artery disease, and the number
f distal anastomoses. Demographic characteristics, clinical de-
ails, and perioperative variables from our database were supple-
ented by review of patient charts, operative notes, and electro-
ardiographic, angiographic, and echocardiographic reports
Abbreviations and Acronyms
AF  atrial fibrillation
CABG coronary artery bypass grafting
CI  confidence interval
SR  sinus rhythm
RR  relative riskTable 1). g
The Journal of Thoracicefinitions
erminologies used in the description of the types of AF in the
iterature can be confusing. The international consensus on nomen-
lature and classification recently released a position paper on the
linical classification of AF,7 which classifies AF into initial event,
aroxysmal, persistent, and permanent types. During the study
eriod this classification was not in use, and data relating to AF
ere recorded using the simpler classification proposed by Cox,8
hich divides AF on the basis of clinical presentation into inter-
ittent and continuous types. However, both classifications share
ommon arrhythmia patterns; paroxysmal and persistent AF are
haracterized by recurrent arrhythmia (eg, intermittent AF), and
ermanent AF (eg, continuous AF) has established arrhythmia. We
herefore categorized preoperative AF on the basis of clinical
resentation into paroxysmal/persistent and permanent types, and
nto short and long duration to enable comparison of clinical
utcomes.
● Paroxysmal/persistent AF describes recurrent AF.
● Permanent AF denotes established AF that is present at all
times.
● Short-duration AF refers to preoperative AF of 3 months’
duration or less.
● Long-duration AF refers to preoperative AF of more than 3
months’ duration.
ollow-up
oth the Social Security Death Index and Mayo Clinic’s patient
egistration were queried for deaths, and certificates were obtained
or all deaths. A survey questionnaire was then sent to all surviving
atients in the study to gather information including symptom
hange, occurrence of adverse cardiac and cerebrovascular events,
ardiac-related hospital readmission after the index CABG oper-
tion, further cardiac interventions, medications, and cardiac
hythm (Table 2).
Follow-up data were available for 257 patients with preopera-
ive AF and 269 matched patients in SR. These 526 patients
onstitute the study population.
tatistical Analysis
he primary end points were (1) mortality, both overall mortality
nd cardiac-related deaths, and (2) major adverse cardiac and
erebrovascular events, which include cardiac death, myocardial
nfarction, heart failure, further cardiac intervention, and stroke.
econdary end points of this study were length of hospital stay,
ardiac-related hospital readmissions, Coumadin and antiarrhyth-
ic drug use, and bleeding/thromboembolic complications.
Categoric variables are expressed as percentages, and continu-
us variables are expressed as the mean  standard deviation,
nless otherwise stated. Univariate analysis was performed using
he chi-square test for qualitative data, the Wilcoxon rank test for
uantitative data, and the Kaplan–Meier method for long-term
utcomes. Multivariable analysis was done using Cox proportional
azards models and logistic regression. The stepwise model selec-
ion procedure was used to identify risk factors associated with
ach end point of interest. If the primary variable of interest (AF
s SR) was selected by the stepwise procedure, then this is the
odel reported in the results section. Otherwise, if the AF/SRrouping variable was not chosen, then it was forced into the final
and Cardiovascular Surgery ● Volume 133, Number 1 183
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A
CDodel provided by the stepwise procedure. The SAS statistical
nalysis system (SAS Institute Inc, Cary, NC) was used for data
nalysis.
esults
n-hospital Outcome
able 1 compares patient demographics and baseline vari-
bles. The 2 groups were similar aside from cardiomegaly
nd diabetes, which were more prevalent in the AF group.
The AF and SR groups did not differ in operative char-
cteristics or rates of perioperative complications. The op-
rative (30-day) mortality in the AF group was 1.6% versus
.9% for the SR group (P .79). Patients with preoperative
F had a longer average length of postoperative hospital
tay compared with patients in SR (9  6 days vs 8  6
ays, P  .0008).
ate Outcome
he median follow-up for the entire study population was
.7 years (maximum 12 years). Both the AF and SR groups
ad an equivalent duration of follow-up (6.7 vs 6.6 years).
ymptom improvement, as measured by change in the an-
ina class (P  .51), and New York Heart Association
unctional class (P  .74) were comparable between the 2
roups. Patients with preoperative AF had a tendency to-
ard more readmissions within 30 days postoperatively for
roblems including congestive heart failure, AF, recurrent
ngina, and cardiac procedures (13% vs 9%, P  .08).
eyond 30 days, the hospital readmission rate was signifi-
ABLE 1. (Continued)
ariable
SR group
(n  269)
No. (%)
AF group
(n  257)
No. (%)
P
value
ilateral 9 (3) 9 (3)
ean crossclamp
time (min)
50  18 50  18 .52
erfusion time 92 32 91  33 .44
ostoperative data
Inotropic support 117 (43) 129 (50) .12
IABP use 17 (6) 11 (4) .30
Reoperation for bleeding 13 (5) 8 (3) .31
Sternal wound infection 2 (1) 1 (0) 1.00
Stroke 8 (3) 8 (3) .93
Prolonged ventilation 20 (7) 26 (10) .28
Renal failure 15 (6) 17 (7) .62
perative death 5 (2) 4 (2) 1.00
ospital length of stay 8.0 5.6 9.3 6.3 .0008
0-d readmission 23 (9) 34 (13) .08
R, Sinus rhythm; AF, atrial fibrillation; BMI, body mass index; NYHA, New
ork Heart Association; COPD, chronic obstructive pulmonary disease; ITA,
nternal thoracic artery; IABP, intra-aortic balloon pump. *Matching
ariables.ABLE 1. Baseline characteristics and in-hospital out-
ome of patients undergoing coronary artery bypass graft-
ng with and without preoperative atrial fibrillation
ariable
SR group
(n  269)
No. (%)
AF group
(n  257)
No. (%)
P
value
emographics
Mean age (y)* 70 8 71  8 .26
Female gender* 57 (21) 54 (21) .96
Mean BMI (kg/m2) 28  5 29  5 .59
linical symptoms
Angina class .16
I 17 (6) 24 (9)
II 27 (10) 14 (5)
III 128 (48) 122 (47)
IV 97 (36) 97 (38)
NYHA class .22
I 11 (4) 7 (3)
II 25 (9) 13 (5)
III 132 (49) 136 (53)
IV 101 (38) 101 (39)
Unstable angina 42 (16) 31 (12) .24
istory
Stroke 27 (10) 27 (11) .86
Carotid endarterectomy 10 (4) 6 (2) .36
Angioplasty/stent 70 (26) 85 (33) .08
omorbidities
Diabetes mellitus 69 (26) 89 (35) .02
Renal insufficiency 13 (5) 14 (5) .75
Hypertension 192 (71) 190 (74) .51
COPD 25 (9) 36 (14) .09
ardiac morbidity
Mean ejection fraction* 0.56 0.16 0.53 0.14 .14
Coronary artery disease* .77
1-vessel 8 (3) 8 (3)
2-vessel 42 (16) 46 (18)
3-vessel 219 (81) 203 (79)
Left main stem disease 74 (28) 80 (31) .36
Myocardial infarction 139 (52) 141 (55) .46
Cardiomegaly 84 (32) 111 (43) .007
perative details
Surgery priority .32
Elective 240 (89) 238 (93)
Urgent 22 (8) 16 (6)
Emergency 7 (3) 3 (1)
Distal anastomosis* .96
1 3 (1) 2 (1)
2 38 (14) 30 (12)
3 115 (43) 114 (44)
4 93 (35) 93 (36)
5 19 (7) 17 (7)
6 1 (0) 1 (0)
ITA use .53
None 11 (4) 15 (6)
Left 247 (92) 233 (91)antly increased in patients with preoperative AF (54% vs
ary 2007
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A
CD2%, P  .0001). Overall (all-causes) mortality (relative
isk [RR] 1.4, P .02) and late cardiac death (RR 2.8,
 .0004) were more likely in the AF group compared
ith the SR group. In general, more major and minor
dverse cardiac events were observed in the AF group (70%
s 52%, P  .0001). Late congestive heart failure (21% vs
%, P  .0002), cardiac rhythm–related intervention (35%
s 18%, P  .0027), and bleeding/thromboembolism (21%
s 12%, P  .05) occurred more often in patients with
reoperative AF. There was, however, no difference in late
ncidences of myocardial infarctions and strokes (Table 2).
s expected, patients with preoperative AF had a higher use
f Coumadin (56% vs 12%, P .0001) and antiarrhythmics
49% vs 14%, P  .0001).
Patients with preoperative AF had comparatively poor late
verall survival and freedom from late cardiac death (Figure 1, A,
). The 1-, 5-, and 10-year overall survivals were 96%, 74%, and
1%, respectively, for the AF group compared with 97%, 83%,
ABLE 2. Late results in the two groups of patients
SR group
Total No.
Frequen
mean
ate all-cause mortality 264 86
linical symptoms 119
Angina class
I 108
II 9
III 1
IV 1
Angina class change
Increase
No change 10
Decrease 109
edications
Coumadin 140 17
Beta-blocker 140 92
ACE inhibitor 139 64
Antiarrhythmics 138 20
ospital admissions 143 45
ardiac rhythm 141
SR 115
AF 24
Paced rhythm 2
dverse events
Cardiac events
Cardiac death 264 16
Myocardial infarction 140 13
Heart failure 140 8
Reintervention 140 25
Stroke 142 14
Bleeding/thromboembolism 140 17
D, Standard deviation; ACE, angiotensin-converting enzyme; SR, sinus rhnd 58%, respectively, for the SR group (P  .02). The corre- t
The Journal of Thoracicponding 1-, 5-, and 10-year freedom from cardiac death values
ere 98%, 88%, and 74%, respectively, for the AF group com-
ared with 100%, 97%, and 90%, respectively, for the SR group
P  .0004). Figure 2 displays the trend of subsequent cardiac
hythm–related intervention after the index CABG operation in
oth groups of patients. More patients with AF underwent subse-
uent cardiac rhythm-related intervention in the form of cardio-
ersion or AF ablation, and in the long term, patients with preop-
rative AF had a 2-fold increase in the risk of subsequent cardiac
hythm-related intervention compared with patients in SR.
reoperative Atrial Fibrillation As a Predictor of
dverse Outcomes After Coronary Artery Bypass
rafting
n the multivariable analysis, preoperative AF was an inde-
endent predictor of prolonged hospital stay (P  .03),
ajor adverse cardiac events (hazard ratio 2.51, 95% con-
dence interval [CI]: 1.65-3.84, P  .0001), all-cause mor-
AF group
P value
) or
Total no.
Frequency (%) or
mean  SD
253 104 (41) .02
95
.55
84 (88)
8 (8)
3 (3)
0 .44
2 (2)
8 (8)
85 (89)
121 68 (56) .0001
114 74(65) .89
115 57 (50) .58
112 55 (49) .0001
133 78 (59) .0001
122 .0001
34 (28)
81 (66)
7 (6)
253 38 (15) .0004
110 11 (10) .85
121 26 (21) .0002
124 41 (33) .003
119 17 (14) .27
114 24 (21) .05
AF, atrial fibrillation.cy (%
 SD
(33)
(91)
(8)
(1)
(1)
0
(8)
(92)
(12)
(66)
(46)
(14)
(32)
(82)
(17)
(1)
(6)
(9)
(6)
(18)
(10)
(12)ality (RR 1.34, 95% CI: 0.995-1.80, P  .05), and cardiac
and Cardiovascular Surgery ● Volume 133, Number 1 185
d
w
s
p
f
b
c
I
T
2
w
p
p
1
s
a
s
p
t
F
A
fi
F
t
A
T
t
A
L
L
Surgery for Acquired Cardiovascular Disease Ngaage et al
1
A
CDeath (hazard ratio 2.75, 95% CI: 1.50-5.02, P  .001); this
as true after controlling for other patient characteristics
uch as chronic obstructive pulmonary disease, diabetes,
ostoperative renal failure, cardiomegaly, congestive heart
ailure, preoperative stroke, and myocardial infarction. Ta-
le 3 shows other independent predictors of adverse out-
ome after CABG.
nfluence of Type and Duration of Atrial Fibrillation
he type of preoperative AF was known with certainty in
25 patients (88%). In this subset, late all-cause mortality
as twice as likely to occur in patients with permanent
reoperative AF compared with patients with paroxysmal/
ersistent AF (RR  2, P  .0007), resulting in 5- and
0-year survivals of 67% and 22% vs 77% and 56%, re-
igure 1. Kaplan–Meier survival curves for patients after CABG.
, Overall survival. B, Freedom from cardiac death. AF, Atrial
brillation; SR, sinus rhythm.pectively (Figure 3, A). However, the rates of cardiac death C
86 The Journal of Thoracic and Cardiovascular Surgery ● Janund other adverse cardiac and cerebrovascular events were
imilar between patients with both types of AF. Among
atients with known duration of AF (118 patients, 46%),
here was no difference in the length of hospital stay,
igure 2. Trends for subsequent cardiac rhythm-related interven-
ion after CABG in patients with preoperative SR and AF. AF,
trial fibrillation; SR, sinus rhythm.
ABLE 3. Predictors of adverse clinical outcome by mul-
ivariate analysis
Odds ratio 95% CI P value
dverse cardiac event and stroke
Preoperative AF 2.4 1.5-3.7 .0001
Diabetes 3.3 1.9-5.9 .0001
History of stroke 3.8 1.4-10.2 .007
Cardiomegaly 2.0 1.3-3.3 .004
Hazard ratio 95% CI P value
ate cardiac death
Preoperative AF 2.7 1.50-5.02 .001
History of stroke 2.8 1.40-5.39 .003
Chronic obstructive
pulmonary disease
2.7 1.41-4.98 .002
Postoperative dialysis 17.6 2.16-143.82 .007
Myocardial infarction 1.9 1.07-3.48 .029
Cardiomegaly 1.8 1.05-3.12 .032
ate all-cause mortality
Preoperative AF 1.3 0.99-1.8 .054
History of stroke 2.4 1.64-3.46 .0001
Chronic obstructive
pulmonary disease
2.0 1.36-2.84 .0003
Myocardial infarction 1.4 1.01-1.834 .043
Cardiomegaly 1.5 1.15-2.07 .003
Diabetes 1.6 1.16-2.13 .004
Postoperative dialysis 11.600 3.02-44.48 .0004I, Confidence interval; AF, atrial fibrillation.
ary 2007
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A
CDdverse cardiac and cerebrovascular events, and overall
urvival between patients with short-duration and long-
uration AF (Figure 3, B).
iscussion
he overall long-term survival of patients with preoperative
F undergoing CABG has been reported to be inferior to
hat of patients without preoperative AF.5 Quader and as-
ociates5 reviewed 46,984 patients who underwent CABG
etween 1972 and 2000 and reported a preoperative AF
revalence rate of 0.96% (451 patients). They identified
reoperative AF both as a marker of severe cardiovascular
isease and as a determinant of poor long-term survival
sing propensity matching. Our patient population differs
igure 3. Kaplan–Meier survival curves for patients with different
ubclasses of preoperative AF after CABG. A, Survival of patients
ith the 2 patterns of AF. B, Comparison of survival on the basis
f AF duration. AF, Atrial fibrillation.onsiderably as evidenced by the 8.7% prevalence of AF. G
The Journal of Thoraciche present study also differs in that we conducted active
ollow-up and evaluated causes of late death and incidences
f late morbid events, as well as the influence of types and
uration of preoperative AF on clinical outcomes.
ong-term Survival and Adverse Cardiac and
erebrovascular Events
reoperative AF is associated with decreased long-term
urvival after CABG. New and notable findings from this
tudy include increased rates of late adverse events, includ-
ng death from cardiac causes such as heart failure and
rrhythmia. Preoperative AF in patients undergoing CABG
ncreased all-cause mortality by 40%, the likelihood of
ardiac death by approximately 3 folds (RR  2.8), and the
isk of major adverse cardiac events by 2.5 times. The
resence of preoperative AF doubled the risk of subsequent
ardiac (rhythm-related) intervention, despite continuing
ptimal medical treatment of AF. The cohort of patients
ith AF in our study were receiving medical treatment with
ate and/or rhythm control and anticoagulation, which may
xplain the relatively low rate of cerebrovascular accident in
he AF group. Similarly, late myocardial infarction was rare
n both groups. Notwithstanding, major cardiac adverse
vents (eg, heart failure and subsequent cardiac interven-
ion) were more frequent in patients with preoperative AF.
mpairment of both atrial and ventricular function occurs in
F,9,10 and this may contribute to the high rate of late
ostoperative congestive heart failure, which leads to clin-
cal deterioration with poor prognosis.11 Together with re-
urrent episodes of rapid AF and recurrent angina, heart
ailure accounted for 86% of late hospital readmissions.
Many patients with AF are symptomatic with palpita-
ions and fatigue, so it is not surprising that patients with AF
ere often readmitted for rate control and/or further
hythm-related intervention such as pacemaker placement
ith or without ablation of the atrioventricular node. Sim-
lar findings have been reported in nonsurgical series.12,13
nticoagulation-related complications, such as gastrointes-
inal bleeding and epistaxis, occurred more often in patients
ith preoperative AF because of their high use of Couma-
in. Both subtherapeutic and supratherapeutic levels of an-
icoagulation resulted in hospital readmission in some pa-
ients with AF in our study.
Beta-blockers and angiotensin-converting enzyme inhib-
tors confer a prognostic benefit in subsets of patients with
oronary artery disease14,15 and after CABG.16 In this study,
ostoperative medical treatment was similar in patients with
nd without preoperative AF and thus does not explain the
ifferences in late survival. Also, the use of antiarrhythmics
or rate or rhythm control did not confer any survival
dvantage among patients with AF.
Among patients with preoperative AF, those with per-
anent AF were twice as likely to have late mortality.
ajewski and Singer17 first reported a differential survival
and Cardiovascular Surgery ● Volume 133, Number 1 187
i
a
o
e
n
i
t
o
m
d
o
f
e
m
a
a
a
P
b
e
i
t
w
d
o
a
p
S
T
o
w
t
d
t
c
t
a
l
n
d
c
w
I
b
a
c
s
m
A
r
T
m
p
s
l
F
r
l
n
w
d
r
C
P
p
m
h
m
e
d
a
v
h
p
w
l
p
c
R
Surgery for Acquired Cardiovascular Disease Ngaage et al
1
A
CDmpact of the clinical type of AF in a study of insurance
pplicants. Electrical and anatomic remodeling of the atria
ccurs in AF18,19 and leads to progression from recurrent to
stablished arrhythmia (“AF begets AF”). It is important to
ote, however, that the duration of preoperative AF did not
nfluence clinical outcomes after CABG. It is possible that
he arbitrary 3-month cutoff used in this study and based on
ur previous report in patients with mitral valve disease20
ay not be long enough in coronary artery disease for the
evelopment of sufficient morphologic changes to influence
utcome.
The preoperative cardiac rhythm of patients did not af-
ect late symptom improvement, probably because of the
ffect of CABG in relieving ischemia. Further, adequate
edical treatment of AF can improve symptoms without
ffecting the long-term morbidity and mortality.21
Preexisting AF exerts a profound impact on prognosis
fter CABG, but it remains to be determined whether AF
blation at the time of CABG would alter long-term results.
reoperative AF is a risk factor for adverse cardiac events
ut a weak predictor of all-cause mortality; frequently co-
xists with cardiomegaly, which has similar effects on clin-
cal outcome (Table 3). Thus, it is possible that the correc-
ion of AF could achieve greater clinical benefit in patients
ithout cardiomegaly. However, even in patients with car-
iomegaly and history of stroke, the likelihood of poor
utcome may also be reduced by AF ablation. These data
lso support consideration of AF surgery in patients with
ermanent AF.
trengths and Limitations
his study was designed to compare the clinical outcomes
f matched groups of patients who had preoperative AF
ith those in preoperative SR and was adequately powered
o detect important differences in the primary and secondary
ependent variables. The comprehensive investigation of
he extent of the impact of preoperative AF on the late
linical outcome in patients managed with optimal medical
reatment is relevant to contemporary practice and therefore
valuable addition to the cardiovascular medicine
iterature.
Although the groups were matched for important prog-
ostic variables, more patients with preoperative AF had
iabetes and cardiomegaly, which can affect outcome. To
ontrol the influence of these variables, we used the step-
ise model selection procedure in the multivariate analysis.
n the subset analysis of the impact of AF types, we com-
ined paroxysmal and persistent AF on the basis of a similar
rrhythmia pattern, because the distinction between the 2
an be subtle and difficult to reliably establish in a retro-
pective study. This categorization is consistent with current
edical and surgical therapeutic strategies of managing AF.
nother potential weakness of this study is recall bias due to
88 The Journal of Thoracic and Cardiovascular Surgery ● Janueliance on self-reporting for follow-up data acquisition.
he influence of this limitation is reduced by the supple-
ental follow-up data collection from hospital records for
atients who attended the Mayo Clinic integrated heath care
ystem. Moreover, the follow-up information obtained re-
ated to major events that patients are more likely to recall.
ollow-up heart rhythm was confirmed by electrocardiog-
aphy in only 15% of patients who were under surveillance
ocally; otherwise, the patients’ responses to the question-
aire were accepted. It is noteworthy that in the patients
ith follow-up electrocardiograms, there was 100% concor-
ance with the questionnaire response for the late cardiac
hythm.
onclusions
reoperative AF in patients undergoing on-pump CABG
redisposes them to high rates of early and late cardiac
orbidity. Hospital stay after surgery is prolonged, and late
ospital readmissions for cardiac-related events are com-
on. Patients with preexisting AF have adverse cardiac
vents more frequently than those in normal SR after CABG
espite optimal postoperative medical treatment with rate
nd/or rhythm control and anticoagulation. Long-term sur-
ival in patients with preoperative AF is steadily reduced by
igher rates of cardiac and all-cause mortality. Patients with
ermanent AF have worse long-term survival compared
ith patients with paroxysmal/persistent AF. Whether ab-
ation of AF at the time of CABG would improve the
rognosis is yet to be determined, but these data support
onsideration of concomitant AF surgery.
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Notice of Correction
Shigemura N, Akashi A, Funaki S, Nakagiri T, Inoue M, Sawabata N, et al. Long-term outcomes
after a variety of video-assisted thoracoscopic lobectomy approaches for clinical stage IA lung cancer:
A multi-institutional study. J Thorac Cardiovasc Surg. 2006;132:507-12.
The authors report the following error in data analysis: Figure 3 shows the postoperative physical
activity of the patients using an accelerometer to quantify their recovery from surgery. The data
pertaining to all patients in one of the participant hospitals who received the a-VATS approach are
inaccurate. All a-VATS results have been removed from the revised Figure 3. As a result, the authors
can no longer conclude that a significant difference exists in the recovery times between the a-VATS
and c-VATS groups. The significant difference in the recovery times between the c-VATS and open
thoracotomy groups remains valid. All other results from the study remain accurate.
Revised Figure 3. Comparison of the postoperative physical ability as determined by Active Tracer and expressed
as the percentage of the preoperative 24-hour value. Time points included are before surgery and 0, 1, 2, 3, 4, 5,
and 6 days postoperatively. Each value represents the mean  standard error at each time point. *P < .05 foroperative days 2 to 5.
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